Hong‐Guo Hu

472 total citations
10 papers, 398 citations indexed

About

Hong‐Guo Hu is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Hong‐Guo Hu has authored 10 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 3 papers in Biomedical Engineering. Recurrent topics in Hong‐Guo Hu's work include interferon and immune responses (4 papers), Immunotherapy and Immune Responses (4 papers) and Immune Response and Inflammation (3 papers). Hong‐Guo Hu is often cited by papers focused on interferon and immune responses (4 papers), Immunotherapy and Immune Responses (4 papers) and Immune Response and Inflammation (3 papers). Hong‐Guo Hu collaborates with scholars based in China, Canada and Belarus. Hong‐Guo Hu's co-authors include Yanmei Li, Jun Wu, Lang Zhao, Wenhao Li, Bo‐Dou Zhang, Wenhao Li, Pu‐Guang Chen, Yong‐Xiang Chen, Qianqian Li and Yufen Zhao and has published in prestigious journals such as Advanced Materials, Biomaterials and Chemical Communications.

In The Last Decade

Hong‐Guo Hu

10 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hong‐Guo Hu China	9	287	206	78	73	59	10	398
Seong Dong Jeong South Korea	11	132 0.5×	172 0.8×	87 1.1×	54 0.7×	48 0.8×	19	441
Emma Reesor Canada	4	159 0.6×	278 1.3×	81 1.0×	45 0.6×	54 0.9×	6	434
Peter Larson United States	8	181 0.6×	115 0.6×	76 1.0×	30 0.4×	56 0.9×	14	326
Charles B. Chesson United States	9	139 0.5×	216 1.0×	36 0.5×	58 0.8×	50 0.8×	12	366
Ismail M. Meraz United States	14	160 0.6×	133 0.6×	70 0.9×	68 0.9×	168 2.8×	21	449
Frances C. Knight United States	7	261 0.9×	184 0.9×	97 1.2×	45 0.6×	63 1.1×	7	382
Yiming Cao China	11	119 0.4×	254 1.2×	89 1.1×	70 1.0×	32 0.5×	19	444
Sergei Pustylnikov United States	8	93 0.3×	270 1.3×	46 0.6×	66 0.9×	154 2.6×	12	490
Mohamed Wehbe United States	5	336 1.2×	166 0.8×	83 1.1×	78 1.1×	91 1.5×	6	395
Jardin Leleux United States	9	253 0.9×	210 1.0×	103 1.3×	18 0.2×	63 1.1×	14	451

Countries citing papers authored by Hong‐Guo Hu

Since Specialization

Citations

This map shows the geographic impact of Hong‐Guo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Guo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Guo Hu more than expected).

Fields of papers citing papers by Hong‐Guo Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Guo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Guo Hu. The network helps show where Hong‐Guo Hu may publish in the future.

Co-authorship network of co-authors of Hong‐Guo Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Guo Hu. A scholar is included among the top collaborators of Hong‐Guo Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Guo Hu. Hong‐Guo Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Li, Wenhao, Jingyun Su, Bo‐Dou Zhang, et al.. (2024). Myeloid Cell‐Triggered In Situ Cell Engineering for Robust Vaccine‐Based Cancer Treatment. Advanced Materials. 36(16). e2308155–e2308155. 6 indexed citations

Zhang, Bo‐Dou, Jun Wu, Wenhao Li, et al.. (2022). STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation. Nano Research. 15(7). 6328–6339. 41 indexed citations

Li, Wenhao, Jun Wu, Lie Wu, et al.. (2021). Black phosphorous nanosheet: A novel immune-potentiating nanoadjuvant for near-infrared-improved immunotherapy. Biomaterials. 273. 120788–120788. 52 indexed citations

Chen, Huai, et al.. (2020). Late-stage peptide and protein modifications through phospha-Michael addition reaction. Chemical Communications. 56(83). 12632–12635. 21 indexed citations

Hu, Hong‐Guo & Yanmei Li. (2020). Emerging Adjuvants for Cancer Immunotherapy. Frontiers in Chemistry. 8. 601–601. 42 indexed citations

Hu, Hong‐Guo, Jun Wu, Bo‐Dou Zhang, Wenhao Li, & Yanmei Li. (2020). Pam₃CSK₄-CDG^SF Augments Antitumor Immunotherapy by Synergistically Activating TLR1/2 and STING. Bioconjugate Chemistry. 31(11). 2499–2503. 21 indexed citations

Wu, Jun, Lang Zhao, Hong‐Guo Hu, Wenhao Li, & Yanmei Li. (2019). Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy. Medicinal Research Reviews. 40(3). 1117–1141. 128 indexed citations

Hu, Hong‐Guo, Pu‐Guang Chen, Guanyu Wang, et al.. (2019). Regulation of Immune Activation by Optical Control of TLR1/2 Heterodimerization. ChemBioChem. 21(8). 1150–1154. 10 indexed citations

Chen, Pu‐Guang, Hong‐Guo Hu, Zhanyi Sun, et al.. (2019). Fully Synthetic Invariant NKT Cell-Dependent Self-Adjuvanting Antitumor Vaccines Eliciting Potent Immune Response in Mice. Molecular Pharmaceutics. 17(2). 417–425. 30 indexed citations

10.

Wu, Jun, Wenhao Li, Pu‐Guang Chen, et al.. (2018). Targeting STING with cyclic di-GMP greatly augmented immune responses of glycopeptide cancer vaccines. Chemical Communications. 54(69). 9655–9658. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact